Inotek Pharmaceuticals Expands Intellectual Property Portfolio with Combination Patent
LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals (NASDAQ: ITEK) expands intellectual property portfolio with combination patent of trabodenoson with a prostaglandin analog for the treatment of intraocular pressure (IOP).
